Lindberg Iris, Shorter James, Wiseman R Luke, Chiti Fabrizio, Dickey Chad A, McLean Pamela J
University of Maryland School of Medicine, Baltimore, Maryland 21201,
University of Pennsylvania, Philadelphia, Pennsylvania 19104.
J Neurosci. 2015 Oct 14;35(41):13853-9. doi: 10.1523/JNEUROSCI.2600-15.2015.
Cellular protein homeostasis (proteostasis) maintains the integrity of the proteome and includes protein synthesis, folding, oligomerization, and turnover; chaperone proteins assist with all of these processes. Neurons appear to be especially susceptible to failures in proteostasis, and this is now increasingly recognized as a major origin of neurodegenerative disease. This review, based on a mini-symposium presented at the 2015 Society for Neuroscience meeting, describes new work in the area of neuronal proteostasis, with a specific focus on the roles and therapeutic uses of protein chaperones. We first present a brief review of protein misfolding and aggregation in neurodegenerative disease. We then discuss different aspects of chaperone control of neuronal proteostasis on topics ranging from chaperone engineering, to chaperone-mediated blockade of protein oligomerization and cytotoxicity, to the potential rescue of neurodegenerative processes using modified chaperone proteins.
Aberrant protein homeostasis within neurons results in protein misfolding and aggregation. In this review, we discuss specific roles for protein chaperones in the oligomerization, assembly, and disaggregation of proteins known to be abnormally folded in neurodegenerative disease. Collectively, our goal is to identify therapeutic mechanisms to reduce the cellular toxicity of abnormal aggregates.
细胞蛋白质稳态(蛋白质平衡)维持蛋白质组的完整性,包括蛋白质合成、折叠、寡聚化和周转;伴侣蛋白协助所有这些过程。神经元似乎对蛋白质平衡的失败特别敏感,现在这一点越来越被认为是神经退行性疾病的主要起源。本综述基于在2015年神经科学学会会议上举办的一个小型研讨会,描述了神经元蛋白质平衡领域的新研究,特别关注蛋白质伴侣的作用和治疗用途。我们首先简要回顾神经退行性疾病中的蛋白质错误折叠和聚集。然后我们讨论伴侣蛋白对神经元蛋白质平衡控制的不同方面,主题包括伴侣蛋白工程、伴侣蛋白介导的蛋白质寡聚化和细胞毒性的阻断,以及使用修饰的伴侣蛋白对神经退行性过程的潜在挽救。
神经元内异常的蛋白质稳态导致蛋白质错误折叠和聚集。在本综述中,我们讨论了蛋白质伴侣在神经退行性疾病中已知异常折叠的蛋白质的寡聚化(oligomerization)、组装和解聚中的具体作用。总的来说,我们的目标是确定治疗机制,以降低异常聚集体的细胞毒性。